Donna A Volpe

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Endoplasmic Reticulum

High Throughput

Top Venues

Pharmaceutical research

The AAPS journal

Expert opinion on drug discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammed Qusa, Hisham Qosa, Donna A Volpe
Evaluation of In Vitro Metabolism- and Transporter-Based Drug Interactions with Sunscreen Active Ingredients. Pharmaceutical research (2024)
Donna A Volpe
Knockout Transporter Cell Lines to Assess Substrate Potential Towards Efflux Transporters. The AAPS journal 26 (4) (2024)
Donna A Volpe
Knockout Transporter Cell Lines to Assess Substrate Potential Towards Efflux Transporters. The AAPS journal 26 (4) (2024)
Mohammed Qusa, Hisham Qosa, Donna A Volpe
Evaluation of In Vitro Metabolism- and Transporter-Based Drug Interactions with Sunscreen Active Ingredients. Pharmaceutical research 41 (8) (2024)
Mohammed Qusa, Hisham Qosa, Donna A Volpe
Evaluation of In Vitro Metabolism- and Transporter-Based Drug Interactions with Sunscreen Active Ingredients. Pharmaceutical research 41 (8) (2024)
Donna A Volpe, Abhay Joshi, Vikram Arya
Do differences in cell lines and methods used for calculation of IC 50 values influence categorisation of drugs as P-glycoprotein substrates and inhibitors? Xenobiotica; the fate of foreign compounds in biological systems 52 (7) (2022)
Phu N Tran, Jiansong Sheng, Aaron L Randolph, Claudia Alvarez Baron, Nicolas Thiebaud, Ming Ren, Min Wu, Lars Johannesen, Donna A Volpe, Dakshesh Patel, Ksenia Blinova, David G Strauss, Wendy W Wu
Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block. PloS one 15 (11) (2020)
Donna A Volpe
Advances in cell-based permeability assays to screen drugs for intestinal absorption. Expert opinion on drug discovery 15 (5) (2020)